METASTATIC BLADDER CARCINOMA
Clinical trials for METASTATIC BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted pill trial offers new hope for Tough-to-Treat urinary cancers
Disease control Recruiting nowThis study is testing whether a pill called olaparib can help control advanced bladder and other urinary cancers that have specific genetic problems in their DNA repair system. It is for patients whose cancer has spread or worsened despite prior treatments like chemotherapy or im…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 01:50 UTC
-
New hope for rare cancers: Triple-Threat therapy trial opens
Disease control Recruiting nowThis study is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—for patients with rare types of bladder, kidney, penile, and other urinary tract cancers that have spread. The goal is to see if this three-drug approach can shrink tumors and control the d…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New support program aims to help bladder cancer patients navigate complex treatment
Symptom relief Recruiting nowThis study is testing an education and navigation support tool designed to help patients with advanced bladder cancer and their caregivers participate more actively in treatment decisions and care planning. The program provides educational resources, connects patients to support …
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Feb 17, 2026 14:36 UTC